BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:BMRN • US09061G1013

58.13 USD
+0.98 (+1.71%)
At close: Feb 6, 2026
58.13 USD
0 (0%)
After Hours: 2/6/2026, 6:22:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
BMRN revenue by date.BMRN revenue by date.
2.096B
13.52%
2.419B
15.42%
2.854B
17.97%
3.239B
13.49%
3.554B
9.73%
3.907B
9.93%
3.945B
0.97%
4.076B
3.32%
4.226B
3.68%
4.072B
-3.64%
4.084B
0.29%
4.142B
1.42%
EBITDA
YoY % growth
BMRN ebitda by date.BMRN ebitda by date.
166.6M
588.43%
290.16M
74.17%
666.468M
129.69%
698.9M
4.87%
1.125B
60.97%
1.276B
13.42%
1.141B
-10.58%
1.288B
12.88%
1.404B
9.01%
1.471B
4.77%
1.477B
0.41%
N/A
EBIT
YoY % growth
BMRN ebit by date.BMRN ebit by date.
64.6M
177.09%
185.774M
187.58%
570.042M
206.85%
661.87M
16.11%
1.092B
64.99%
1.368B
25.27%
1.269B
-7.24%
1.454B
14.58%
1.62B
11.42%
1.531B
-5.49%
1.498B
-2.16%
1.503B
0.33%
Operating Margin
BMRN operating margin by date.BMRN operating margin by date.
3.08%7.68%19.97%20.43%30.73%35.01%32.17%35.67%38.33%37.60%36.68%36.29%
EPS
YoY % growth
BMRN eps by date.BMRN eps by date.
0.29
180.56%
0.95
227.59%
2.21
132.63%
2.83
28.21%
4.64
63.90%
5.49
18.25%
6.95
26.49%
7.65
10.13%
7.72
0.87%
7.08
-8.26%
7.10
0.24%
7.23
1.92%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.61
-3.91%
1.08
14.10%
1.10
-10.36%
1.25
880.17%
1.29
109.16%
Revenue
Q2Q % growth
843.89M
12.92%
837.25M
12.36%
862.55M
4.50%
912.01M
17.51%
937.65M
11.11%
EBITDA
Q2Q % growth
138M
-48.44%
256.85M
4.43%
286.52M
-9.76%
266.32M
2,043.08%
282.23M
104.51%
EBIT
Q2Q % growth
172.44M
0.70%
252.43M
12.75%
263.14M
-4.96%
296.99M
736.06%
317.81M
84.30%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.16
-129.09%
0.38-0.54-142.18%
Q2 2025
Q2Q % growth
1.23
119.64%
0.850.3844.44%
Q1 2025
Q2Q % growth
0.95
106.52%
0.720.2331.48%
Q4 2024
Q2Q % growth
0.64
255.56%
0.540.1018.42%
Q3 2024
Q2Q % growth
0.55
161.90%
0.530.024.22%
Q2 2024
Q2Q % growth
0.56
93.10%
0.360.2057.23%
Q1 2024
Q2Q % growth
0.46
70.37%
0.350.1130.72%
Q4 2023
Q2Q % growth
0.18 0.24-0.06-24.46%
Q3 2023
Q2Q % growth
0.21
625.00%
0.24-0.03-12.05%
Q2 2023
Q2Q % growth
0.29
93.33%
0.240.0522.09%
Q1 2023
Q2Q % growth
0.27
50.00%
0.180.0947.54%
Q4 2022
Q2Q % growth
0.00
100.00%
-0.070.07100.00%
Q3 2022
Q2Q % growth
-0.04
80.00%
-0.01-0.03-361.36%
Q2 2022
Q2Q % growth
0.15
114.29%
0.120.0329.99%
Q1 2022
Q2Q % growth
0.18
100.00%
0.180.002.52%
Q4 2021
Q2Q % growth
-0.32
-366.67%
-0.330.012.37%
Q3 2021
Q2Q % growth
-0.20
-104.99%
-0.250.0520.94%
Q2 2021
Q2Q % growth
0.07
450.00%
-0.120.19158.23%
Q1 2021
Q2Q % growth
0.09
-79.55%
-0.070.16231.05%
Q4 2020
Q2Q % growth
0.12 -0.190.31161.70%
Q3 2020
Q2Q % growth
4.01 1.262.75218.06%
Q2 2020
Q2Q % growth
-0.02 -0.100.0879.94%
Q1 2020
Q2Q % growth
0.44 0.050.39723.70%
BMRN Yearly EPS VS EstimatesBMRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
776.133M
4.08%
796.24M-20.107M-2.53%
Q2 2025
Q2Q % growth
825.41M
15.92%
775.18M50.23M6.48%
Q1 2025
Q2Q % growth
745.145M
14.84%
755.53M-10.385M-1.37%
Q4 2024
Q2Q % growth
747.313M
15.65%
727.71M19.603M2.69%
Q3 2024
Q2Q % growth
745.74M
28.28%
714.18M31.56M4.42%
Q2 2024
Q2Q % growth
712.029M
19.61%
675.29M36.739M5.44%
Q1 2024
Q2Q % growth
648.833M
8.79%
664.82M-15.987M-2.40%
Q4 2023
Q2Q % growth
646.207M
20.22%
649.62M-3.413M-0.53%
Q3 2023
Q2Q % growth
581.329M
15.05%
620.85M-39.521M-6.37%
Q2 2023
Q2Q % growth
595.275M
11.52%
607.14M-11.865M-1.95%
Q1 2023
Q2Q % growth
596.415M
14.83%
582.04M14.375M2.47%
Q4 2022
Q2Q % growth
537.5M
19.50%
547.71M-10.21M-1.86%
Q3 2022
Q2Q % growth
505.3M
23.64%
528.78M-23.48M-4.44%
Q2 2022
Q2Q % growth
533.8M
6.40%
531.9M1.9M0.36%
Q1 2022
Q2Q % growth
519.4M
6.87%
517.67M1.73M0.33%
Q4 2021
Q2Q % growth
449.8M
-0.51%
451.23M-1.43M-0.32%
Q3 2021
Q2Q % growth
408.7M
-14.28%
444.03M-35.33M-7.96%
Q2 2021
Q2Q % growth
501.7M
16.81%
457.47M44.23M9.67%
Q1 2021
Q2Q % growth
486M
-3.21%
455.38M30.62M6.72%
Q4 2020
Q2Q % growth
452.1M 449.03M3.07M0.68%
Q3 2020
Q2Q % growth
476.8M 463.74M13.06M2.82%
Q2 2020
Q2Q % growth
429.5M 426.99M2.51M0.59%
Q1 2020
Q2Q % growth
502.1M 478.15M23.95M5.01%
BMRN Yearly Revenue VS EstimatesBMRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-29.03% -25.47% -5.52% -16.53%
Revenue0.68% 0.61% 0.12% 0.12%